Senate Budget Draft Would Be Less Generous To US FDA Than House For FY2023

Senate appropriations bill would take back some of increase House offered Center for Drug Evaluation and Research and other FDA programs, setting up negotiations as start of FY2023 nears.

comparing coins — • Source: Shutterstock

The Senate is starting deliberations on US Food and Drug Administration funding for fiscal year 2023 from a less generous stance than the House, setting the stage for negotiations over potentially wide differences before 1 October, when the new spending plan would start.

Both would give increases to the agency, but the Senate proposal is more conservative. The current Senate figures, outlined in...